Related Experiment Video
Updated: Jun 6, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
A new prognostic index for one-year survival in incident hemodialysis patients
Sergio Marinovich1, Carlos Lavorato, Claudio Moriñigo
1Committee on Epidemiology and Registration, Argentina Society of Nephrology, Buenos Aires, Argentina. smarinovich@fibertel.com.ar
Insights
A new comorbidity index (NI) was developed for patients starting hemodialysis, outperforming existing scores in predicting one-year survival for end-stage renal disease (ESRD) patients.
Area of Science:
- Nephrology
- Epidemiology
- Biostatistics
Background:
- Comorbidity scoring is crucial for patients initiating chronic hemodialysis.
- Existing prognostic indexes lack widespread acceptance in predicting survival.
- Developing a reliable index is essential for managing end-stage renal disease (ESRD).
Purpose of the Study:
- To develop a novel prognostic index (NI) for patients beginning renal replacement therapy.
- To evaluate the predictive accuracy of the NI for one-year survival.
- To compare the NI with established comorbidity scores.
Main Methods:
- A cohort of 5,360 incident ESRD patients requiring dialysis was analyzed.
- A novel comorbidity index (NI) was developed and validated.
- Cox proportional hazard regression and ROC curve analysis were used to assess survival prediction.
Main Results:
- The novel index (NI) demonstrated superior one-year survival prediction (AUC=0.74) compared to Charlson (0.70), ACPI (0.68), Kahn-Wright (0.67), and Hemmelgarn (0.63) indexes.
- The NI identified a high-risk group with a 43% one-year survival rate.
- Statistical analysis showed significant differences in predictive performance.
Conclusions:
- The novel index (NI) is recommended for its enhanced ability to predict one-year survival in incident hemodialysis patients.
- The NI offers improved prognostic accuracy for ESRD patients entering renal replacement therapy.
- This index can aid in clinical decision-making and patient management.
Purpose:
Although scoring comorbidities for patients beginning chronic hemodialysis has proved significant and has led researchers to develop several indexes, none of them has been extensively accepted. The aim of this study was to: 1) develop a prognostic index for patients entering renal replacement therapy; and 2) identify which one of the available scores better predicts one-year survival.
Methods:
Records from 5,360 incident dialysis-requiring ESRD individuals were studied and a novel comorbidity index (NI) was developed. The agreement of this NI with the Charlson age-comorbidity, Kahn-Wright, ACPI, and Hemmelgarn indexes was assessed to identify which one better predicts one-year survival. The Cox proportional hazard regression with time-dependent covariates was used to analyze survival and the area under the receiver operating characteristic (ROC) curve was calculated to assess the ability of this score to discriminate between prognoses and to compare this NI with indexes already in use.
Results:
16 of the original 19 predictor variables displayed hazard ratios =1.2. Although the area under the ROC curves for all the indexes compared were significantly different from 0.5, the NI showed better performance characteristics (0.74 vs. 0.70 for Charlson's, 0.68 for ACPI, 0.67 for Khan-Wright's and 0.63 for Hemmelgarn's). Compared with the Charlson score, the z statistic was 7.78 (p<0.001). One-year survival estimate for the high-risk group was 43% with the NI and ranged from 66% to 72% when assessed through other indexes.
Conclusions:
We recommend the use of this NI because it better predicts the one-year survival probability of incident hemodialysis-requiring ESRD individuals.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate